Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Research into antibiotic-resistant E. coli

Estimates reveal effect of chicken production on humans

Research has revealed that approximately 280 people die every year in the UK as a result of antibiotic-resistant E. coli, acquired from chicken.

The study, carried out by an international team of scientists, looked at the effect of using third-generation cephalosporin – a class of antibiotics – in chicken production.

It is known that the method is causing a rise the number of E. coli cases that are resistant to antibiotics, which is called extended-spectrum beta-lactamase (ESBL) E coli.

The team used Dutch genetic fingerprinting to find a reliable estimate of the number of human blood poisoning infections and deaths caused by ESBL E. coli that have come about as a result of consuming chicken.

They found that chicken production is, according to their analysis, responsible for 1,580 cases of ESBL E. coli blood poisoning every year in the UK.

Furthermore, it was revealed that
each year poultry-associated ESBL E. coli causes an additional 12,500 days in UK hospitals for "last-resort" antibiotic treatment.

"This is the first detailed estimate to emerge of the human-health consequences from the use of antibiotics in European agriculture," said Richard Young, policy adviser at the Soil Association.

"It indicated that large numbers of people die of resistant infections due to the over-reliance on antibiotics in intensive livestock farming."

He added that there are also major additional costs to the NHS from treating patients – even when they survive an ESBL E. coli infection.

Related News
Concerns over resistant E.coli superbugs
Antibiotics a key issue at G8

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
BSAVA publishes fifth Manual of Canine and Feline Neurology

The BSAVA has published the fifth edition of its BSAVA Manual of Canine and Feline Neurology.

The new edition has been reviewed and updated, including new developments in diagnostics, therapeutic approaches and clinical decision-making. It is structured to support clinicians through diagnosis, treatment and long-term management.

The guide features five new chapters covering acute myelopathies, chronic myelopathies, emergency protocols, neurotoxicology and neuro-oncology.

It also includes over 100 videos, including demonstrations of neurological examinations, clinical presentations and diagnostic procedures.

Nicola Lloyd, publishing manager, said: "Whether you're a general practitioner seeking practical guidance, or a specialist aiming to refine your expertise, this edition remains an indispensable reference for anyone involved in the care of neurologically compromised dogs and cats."